[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:bone-marrow-failure-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":68,"states":69},"Bone Marrow Failure Syndrome",9,7,[8,16,22,29,35,41,48,54,61],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05194397","Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors",[12],"Phase 2","RECRUITING","2026-08-26T02:16:03.788292Z","2026-05-05T02:43:28.669280Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04356469","TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children",[12],"2026-08-26T02:15:38.131683Z","2026-05-05T02:43:29.170490Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT02356653","Expanded Access Protocol Using CD3+\u002FCD19+ Depleted PBSC",[26],"Early Phase 1","2026-08-26T02:16:08.402952Z","2026-05-05T02:43:29.132129Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT03314974","Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders",[12],"2026-08-26T02:16:14.341106Z","2026-05-05T02:43:28.206546Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05805605","Allo HSCT Using RIC and PTCy for Hematological Diseases",[12],"2026-08-26T02:17:29.353236Z","2026-05-05T02:43:28.075410Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT03128996","Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders",[45],"Phase 1\u002FPhase 2","2026-08-26T02:18:24.494016Z","2026-05-05T02:43:26.748524Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT02958462","Pre-myeloid Cancer and Bone Marrow Failure Clinic Study",[],"2026-08-26T02:16:16.995720Z","2026-05-05T02:43:27.746243Z",{"nct_id":55,"title":56,"phases":57,"status":58,"updated_at":59,"content_modified":60},"NCT07712562","A Phase 1\u002F2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes",[45],"NOT_YET_RECRUITING","2026-08-26T02:15:03.757872Z","2026-07-30T01:46:14.436804Z",{"nct_id":62,"title":63,"phases":64,"status":58,"updated_at":66,"content_modified":67},"NCT07585136","Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders",[65],"Phase 1","2026-08-26T02:17:30.961790Z","2026-05-29T15:36:40.197853Z",[],[70,74],{"state":71,"count":72,"slug":73},"Florida",3,"florida",{"state":75,"count":72,"slug":76},"Minnesota","minnesota"]